Cargando…
Renal and Red Marrow Dosimetry in Peptide Receptor Radionuclide Therapy: 20 Years of History and Ahead
The development of dosimetry and studies in peptide receptor radionuclide therapy (PRRT) over the past two decades are reviewed. Differences in kidney and bone marrow toxicity reported between (90)Y, (177)Lu and external beam radiotherapy (EBRT) are discussed with regard to the physical properties o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347073/ https://www.ncbi.nlm.nih.gov/pubmed/34361092 http://dx.doi.org/10.3390/ijms22158326 |